instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Foetal exposure during pregnancy'. | The Ex utero intrapartum treatment (EXIT) procedure: case report of a multidisciplinary team approach.
The EXIT-to-airway procedure is aimed to provide the time required to secure airways when an extrinsic or intrinsic fetal mass raise concerns about airways control at delivery. Due to the rarity of the procedure, we a... | FENTANYL CITRATE, METOCLOPRAMIDE, MIDAZOLAM, NITROGLYCERIN, PANTOPRAZOLE, REMIFENTANIL, ROCURONIUM BROMIDE, SEVOFLURANE, THIOPENTAL | DrugsGivenReaction | CC BY-NC-SA | 33944827 | 19,595,531 | 2021-04-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neck mass'. | The Ex utero intrapartum treatment (EXIT) procedure: case report of a multidisciplinary team approach.
The EXIT-to-airway procedure is aimed to provide the time required to secure airways when an extrinsic or intrinsic fetal mass raise concerns about airways control at delivery. Due to the rarity of the procedure, we a... | FENTANYL CITRATE, METOCLOPRAMIDE, MIDAZOLAM, NITROGLYCERIN, PANTOPRAZOLE, REMIFENTANIL, ROCURONIUM BROMIDE, SEVOFLURANE, THIOPENTAL | DrugsGivenReaction | CC BY-NC-SA | 33944827 | 19,595,531 | 2021-04-30 |
What is the weight of the patient? | The Ex utero intrapartum treatment (EXIT) procedure: case report of a multidisciplinary team approach.
The EXIT-to-airway procedure is aimed to provide the time required to secure airways when an extrinsic or intrinsic fetal mass raise concerns about airways control at delivery. Due to the rarity of the procedure, we a... | 3.36 kg. | Weight | CC BY-NC-SA | 33944827 | 19,595,531 | 2021-04-30 |
What was the administration route of drug 'FENTANYL CITRATE'? | The Ex utero intrapartum treatment (EXIT) procedure: case report of a multidisciplinary team approach.
The EXIT-to-airway procedure is aimed to provide the time required to secure airways when an extrinsic or intrinsic fetal mass raise concerns about airways control at delivery. Due to the rarity of the procedure, we a... | Transplacental | DrugAdministrationRoute | CC BY-NC-SA | 33944827 | 19,595,531 | 2021-04-30 |
What was the administration route of drug 'METOCLOPRAMIDE'? | The Ex utero intrapartum treatment (EXIT) procedure: case report of a multidisciplinary team approach.
The EXIT-to-airway procedure is aimed to provide the time required to secure airways when an extrinsic or intrinsic fetal mass raise concerns about airways control at delivery. Due to the rarity of the procedure, we a... | Transplacental | DrugAdministrationRoute | CC BY-NC-SA | 33944827 | 19,595,531 | 2021-04-30 |
What was the administration route of drug 'MIDAZOLAM'? | The Ex utero intrapartum treatment (EXIT) procedure: case report of a multidisciplinary team approach.
The EXIT-to-airway procedure is aimed to provide the time required to secure airways when an extrinsic or intrinsic fetal mass raise concerns about airways control at delivery. Due to the rarity of the procedure, we a... | Transplacental | DrugAdministrationRoute | CC BY-NC-SA | 33944827 | 19,595,531 | 2021-04-30 |
What was the administration route of drug 'NITROGLYCERIN'? | The Ex utero intrapartum treatment (EXIT) procedure: case report of a multidisciplinary team approach.
The EXIT-to-airway procedure is aimed to provide the time required to secure airways when an extrinsic or intrinsic fetal mass raise concerns about airways control at delivery. Due to the rarity of the procedure, we a... | Transplacental | DrugAdministrationRoute | CC BY-NC-SA | 33944827 | 19,595,531 | 2021-04-30 |
What was the administration route of drug 'PANTOPRAZOLE'? | The Ex utero intrapartum treatment (EXIT) procedure: case report of a multidisciplinary team approach.
The EXIT-to-airway procedure is aimed to provide the time required to secure airways when an extrinsic or intrinsic fetal mass raise concerns about airways control at delivery. Due to the rarity of the procedure, we a... | Transplacental | DrugAdministrationRoute | CC BY-NC-SA | 33944827 | 19,595,531 | 2021-04-30 |
What was the administration route of drug 'REMIFENTANIL'? | The Ex utero intrapartum treatment (EXIT) procedure: case report of a multidisciplinary team approach.
The EXIT-to-airway procedure is aimed to provide the time required to secure airways when an extrinsic or intrinsic fetal mass raise concerns about airways control at delivery. Due to the rarity of the procedure, we a... | Transplacental | DrugAdministrationRoute | CC BY-NC-SA | 33944827 | 19,595,531 | 2021-04-30 |
What was the administration route of drug 'ROCURONIUM BROMIDE'? | The Ex utero intrapartum treatment (EXIT) procedure: case report of a multidisciplinary team approach.
The EXIT-to-airway procedure is aimed to provide the time required to secure airways when an extrinsic or intrinsic fetal mass raise concerns about airways control at delivery. Due to the rarity of the procedure, we a... | Transplacental | DrugAdministrationRoute | CC BY-NC-SA | 33944827 | 19,595,531 | 2021-04-30 |
What was the administration route of drug 'SEVOFLURANE'? | The Ex utero intrapartum treatment (EXIT) procedure: case report of a multidisciplinary team approach.
The EXIT-to-airway procedure is aimed to provide the time required to secure airways when an extrinsic or intrinsic fetal mass raise concerns about airways control at delivery. Due to the rarity of the procedure, we a... | Transplacental | DrugAdministrationRoute | CC BY-NC-SA | 33944827 | 19,595,531 | 2021-04-30 |
What was the administration route of drug 'THIOPENTAL'? | The Ex utero intrapartum treatment (EXIT) procedure: case report of a multidisciplinary team approach.
The EXIT-to-airway procedure is aimed to provide the time required to secure airways when an extrinsic or intrinsic fetal mass raise concerns about airways control at delivery. Due to the rarity of the procedure, we a... | Transplacental | DrugAdministrationRoute | CC BY-NC-SA | 33944827 | 19,595,531 | 2021-04-30 |
What was the dosage of drug 'FENTANYL CITRATE'? | The Ex utero intrapartum treatment (EXIT) procedure: case report of a multidisciplinary team approach.
The EXIT-to-airway procedure is aimed to provide the time required to secure airways when an extrinsic or intrinsic fetal mass raise concerns about airways control at delivery. Due to the rarity of the procedure, we a... | MATERNAL DOSE (1 MICROGRAM/KILOGRAM) | DrugDosageText | CC BY-NC-SA | 33944827 | 19,595,531 | 2021-04-30 |
What was the dosage of drug 'METOCLOPRAMIDE'? | The Ex utero intrapartum treatment (EXIT) procedure: case report of a multidisciplinary team approach.
The EXIT-to-airway procedure is aimed to provide the time required to secure airways when an extrinsic or intrinsic fetal mass raise concerns about airways control at delivery. Due to the rarity of the procedure, we a... | MATERNAL DOSE (10 MILLIGRAM) | DrugDosageText | CC BY-NC-SA | 33944827 | 19,595,531 | 2021-04-30 |
What was the dosage of drug 'MIDAZOLAM'? | The Ex utero intrapartum treatment (EXIT) procedure: case report of a multidisciplinary team approach.
The EXIT-to-airway procedure is aimed to provide the time required to secure airways when an extrinsic or intrinsic fetal mass raise concerns about airways control at delivery. Due to the rarity of the procedure, we a... | MATERNAL DOSE (2 MILLIGRAM) | DrugDosageText | CC BY-NC-SA | 33944827 | 19,595,531 | 2021-04-30 |
What was the dosage of drug 'PANTOPRAZOLE'? | The Ex utero intrapartum treatment (EXIT) procedure: case report of a multidisciplinary team approach.
The EXIT-to-airway procedure is aimed to provide the time required to secure airways when an extrinsic or intrinsic fetal mass raise concerns about airways control at delivery. Due to the rarity of the procedure, we a... | MATERNAL DOSE (40 MILLIGRAM) | DrugDosageText | CC BY-NC-SA | 33944827 | 19,595,531 | 2021-04-30 |
What was the dosage of drug 'REMIFENTANIL'? | The Ex utero intrapartum treatment (EXIT) procedure: case report of a multidisciplinary team approach.
The EXIT-to-airway procedure is aimed to provide the time required to secure airways when an extrinsic or intrinsic fetal mass raise concerns about airways control at delivery. Due to the rarity of the procedure, we a... | MATERNAL DOSE: 0.1 TO 0.3 MCG/KG/MIN | DrugDosageText | CC BY-NC-SA | 33944827 | 19,595,531 | 2021-04-30 |
What was the dosage of drug 'ROCURONIUM BROMIDE'? | The Ex utero intrapartum treatment (EXIT) procedure: case report of a multidisciplinary team approach.
The EXIT-to-airway procedure is aimed to provide the time required to secure airways when an extrinsic or intrinsic fetal mass raise concerns about airways control at delivery. Due to the rarity of the procedure, we a... | MATERNAL DOSE (0.6 MILLIGRAM/KILOGRAM) | DrugDosageText | CC BY-NC-SA | 33944827 | 19,595,531 | 2021-04-30 |
What was the dosage of drug 'SEVOFLURANE'? | The Ex utero intrapartum treatment (EXIT) procedure: case report of a multidisciplinary team approach.
The EXIT-to-airway procedure is aimed to provide the time required to secure airways when an extrinsic or intrinsic fetal mass raise concerns about airways control at delivery. Due to the rarity of the procedure, we a... | MATERNAL DOSE: UNK | DrugDosageText | CC BY-NC-SA | 33944827 | 19,595,531 | 2021-04-30 |
What was the dosage of drug 'THIOPENTAL'? | The Ex utero intrapartum treatment (EXIT) procedure: case report of a multidisciplinary team approach.
The EXIT-to-airway procedure is aimed to provide the time required to secure airways when an extrinsic or intrinsic fetal mass raise concerns about airways control at delivery. Due to the rarity of the procedure, we a... | MATERNAL DOSE: 4-6 MG/KG | DrugDosageText | CC BY-NC-SA | 33944827 | 19,595,531 | 2021-04-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Epilepsy'. | An uncommon case of nonconvulsive status epilepticus successfully treated with enteral Brivaracetam.
We present a case of a woman affected by nonconvulsive status epilepticus (NCSE) caused by cerebral hyperperfusion syndrome (CHS) after carotid endarterectomy (CEA) who was successfully treated with Brivaracetam (BRV) a... | LACOSAMIDE, LEVETIRACETAM, MANNITOL, PHENYTOIN | DrugsGivenReaction | CC BY-NC-SA | 33944839 | 19,309,907 | 2021-04-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Multiple-drug resistance'. | An uncommon case of nonconvulsive status epilepticus successfully treated with enteral Brivaracetam.
We present a case of a woman affected by nonconvulsive status epilepticus (NCSE) caused by cerebral hyperperfusion syndrome (CHS) after carotid endarterectomy (CEA) who was successfully treated with Brivaracetam (BRV) a... | ACETAMINOPHEN, BRIVARACETAM, FUROSEMIDE, LACOSAMIDE, LEVETIRACETAM, LORAZEPAM, MANNITOL, PHENYTOIN | DrugsGivenReaction | CC BY-NC-SA | 33944839 | 19,281,273 | 2021-04-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use issue'. | An uncommon case of nonconvulsive status epilepticus successfully treated with enteral Brivaracetam.
We present a case of a woman affected by nonconvulsive status epilepticus (NCSE) caused by cerebral hyperperfusion syndrome (CHS) after carotid endarterectomy (CEA) who was successfully treated with Brivaracetam (BRV) a... | ACETAMINOPHEN, BRIVARACETAM, FUROSEMIDE, LACOSAMIDE, LEVETIRACETAM, LORAZEPAM, MANNITOL, PHENYTOIN | DrugsGivenReaction | CC BY-NC-SA | 33944839 | 19,281,273 | 2021-04-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Status epilepticus'. | An uncommon case of nonconvulsive status epilepticus successfully treated with enteral Brivaracetam.
We present a case of a woman affected by nonconvulsive status epilepticus (NCSE) caused by cerebral hyperperfusion syndrome (CHS) after carotid endarterectomy (CEA) who was successfully treated with Brivaracetam (BRV) a... | ACETAMINOPHEN, BRIVARACETAM, FUROSEMIDE, LACOSAMIDE, LEVETIRACETAM, LORAZEPAM, MANNITOL, PHENYTOIN | DrugsGivenReaction | CC BY-NC-SA | 33944839 | 19,281,273 | 2021-04-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy non-responder'. | An uncommon case of nonconvulsive status epilepticus successfully treated with enteral Brivaracetam.
We present a case of a woman affected by nonconvulsive status epilepticus (NCSE) caused by cerebral hyperperfusion syndrome (CHS) after carotid endarterectomy (CEA) who was successfully treated with Brivaracetam (BRV) a... | ACETAMINOPHEN, FUROSEMIDE, LACOSAMIDE, LEVETIRACETAM, MANNITOL, PHENYTOIN | DrugsGivenReaction | CC BY-NC-SA | 33944839 | 19,785,477 | 2021-04-30 |
What was the administration route of drug 'ACETAMINOPHEN'? | An uncommon case of nonconvulsive status epilepticus successfully treated with enteral Brivaracetam.
We present a case of a woman affected by nonconvulsive status epilepticus (NCSE) caused by cerebral hyperperfusion syndrome (CHS) after carotid endarterectomy (CEA) who was successfully treated with Brivaracetam (BRV) a... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-SA | 33944839 | 19,785,477 | 2021-04-30 |
What was the administration route of drug 'FUROSEMIDE'? | An uncommon case of nonconvulsive status epilepticus successfully treated with enteral Brivaracetam.
We present a case of a woman affected by nonconvulsive status epilepticus (NCSE) caused by cerebral hyperperfusion syndrome (CHS) after carotid endarterectomy (CEA) who was successfully treated with Brivaracetam (BRV) a... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-SA | 33944839 | 19,785,477 | 2021-04-30 |
What was the administration route of drug 'LACOSAMIDE'? | An uncommon case of nonconvulsive status epilepticus successfully treated with enteral Brivaracetam.
We present a case of a woman affected by nonconvulsive status epilepticus (NCSE) caused by cerebral hyperperfusion syndrome (CHS) after carotid endarterectomy (CEA) who was successfully treated with Brivaracetam (BRV) a... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-SA | 33944839 | 19,785,477 | 2021-04-30 |
What was the administration route of drug 'LEVETIRACETAM'? | An uncommon case of nonconvulsive status epilepticus successfully treated with enteral Brivaracetam.
We present a case of a woman affected by nonconvulsive status epilepticus (NCSE) caused by cerebral hyperperfusion syndrome (CHS) after carotid endarterectomy (CEA) who was successfully treated with Brivaracetam (BRV) a... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-SA | 33944839 | 19,309,907 | 2021-04-30 |
What was the administration route of drug 'LORAZEPAM'? | An uncommon case of nonconvulsive status epilepticus successfully treated with enteral Brivaracetam.
We present a case of a woman affected by nonconvulsive status epilepticus (NCSE) caused by cerebral hyperperfusion syndrome (CHS) after carotid endarterectomy (CEA) who was successfully treated with Brivaracetam (BRV) a... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-SA | 33944839 | 19,281,273 | 2021-04-30 |
What was the administration route of drug 'PHENYTOIN'? | An uncommon case of nonconvulsive status epilepticus successfully treated with enteral Brivaracetam.
We present a case of a woman affected by nonconvulsive status epilepticus (NCSE) caused by cerebral hyperperfusion syndrome (CHS) after carotid endarterectomy (CEA) who was successfully treated with Brivaracetam (BRV) a... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-SA | 33944839 | 19,785,477 | 2021-04-30 |
What was the dosage of drug 'BRIVARACETAM'? | An uncommon case of nonconvulsive status epilepticus successfully treated with enteral Brivaracetam.
We present a case of a woman affected by nonconvulsive status epilepticus (NCSE) caused by cerebral hyperperfusion syndrome (CHS) after carotid endarterectomy (CEA) who was successfully treated with Brivaracetam (BRV) a... | 200 MILLIGRAM/DAY | DrugDosageText | CC BY-NC-SA | 33944839 | 19,281,273 | 2021-04-30 |
What was the dosage of drug 'MANNITOL'? | An uncommon case of nonconvulsive status epilepticus successfully treated with enteral Brivaracetam.
We present a case of a woman affected by nonconvulsive status epilepticus (NCSE) caused by cerebral hyperperfusion syndrome (CHS) after carotid endarterectomy (CEA) who was successfully treated with Brivaracetam (BRV) a... | UNKNOWN DOSE | DrugDosageText | CC BY-NC-SA | 33944839 | 19,281,273 | 2021-04-30 |
What was the outcome of reaction 'Epilepsy'? | An uncommon case of nonconvulsive status epilepticus successfully treated with enteral Brivaracetam.
We present a case of a woman affected by nonconvulsive status epilepticus (NCSE) caused by cerebral hyperperfusion syndrome (CHS) after carotid endarterectomy (CEA) who was successfully treated with Brivaracetam (BRV) a... | Recovered | ReactionOutcome | CC BY-NC-SA | 33944839 | 19,309,907 | 2021-04-30 |
What was the outcome of reaction 'Status epilepticus'? | An uncommon case of nonconvulsive status epilepticus successfully treated with enteral Brivaracetam.
We present a case of a woman affected by nonconvulsive status epilepticus (NCSE) caused by cerebral hyperperfusion syndrome (CHS) after carotid endarterectomy (CEA) who was successfully treated with Brivaracetam (BRV) a... | Recovered | ReactionOutcome | CC BY-NC-SA | 33944839 | 19,281,273 | 2021-04-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Aphasia'. | Efficacy and safety of lacosamide in the treatment of status epilepticus in a patient with comorbidities.
Efficacy, safety and tolerability of lacosamide in the treatment of status epilepticus are well described. However, other evidence of its pharmacologic profile in elderly patients with other comorbidities seems war... | LEVETIRACETAM, VALPROIC ACID | DrugsGivenReaction | CC BY-NC-SA | 33944850 | 19,275,909 | 2021-04-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dyskinesia'. | Efficacy and safety of lacosamide in the treatment of status epilepticus in a patient with comorbidities.
Efficacy, safety and tolerability of lacosamide in the treatment of status epilepticus are well described. However, other evidence of its pharmacologic profile in elderly patients with other comorbidities seems war... | DIAZEPAM, LACOSAMIDE, LEVETIRACETAM, VALPROIC ACID | DrugsGivenReaction | CC BY-NC-SA | 33944850 | 19,387,105 | 2021-04-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use issue'. | Efficacy and safety of lacosamide in the treatment of status epilepticus in a patient with comorbidities.
Efficacy, safety and tolerability of lacosamide in the treatment of status epilepticus are well described. However, other evidence of its pharmacologic profile in elderly patients with other comorbidities seems war... | DIAZEPAM, LACOSAMIDE, LEVETIRACETAM, VALPROIC ACID | DrugsGivenReaction | CC BY-NC-SA | 33944850 | 19,284,174 | 2021-04-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyrexia'. | Efficacy and safety of lacosamide in the treatment of status epilepticus in a patient with comorbidities.
Efficacy, safety and tolerability of lacosamide in the treatment of status epilepticus are well described. However, other evidence of its pharmacologic profile in elderly patients with other comorbidities seems war... | DIAZEPAM, LACOSAMIDE, LEVETIRACETAM, VALPROIC ACID | DrugsGivenReaction | CC BY-NC-SA | 33944850 | 19,387,105 | 2021-04-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tachypnoea'. | Efficacy and safety of lacosamide in the treatment of status epilepticus in a patient with comorbidities.
Efficacy, safety and tolerability of lacosamide in the treatment of status epilepticus are well described. However, other evidence of its pharmacologic profile in elderly patients with other comorbidities seems war... | DIAZEPAM, LACOSAMIDE, LEVETIRACETAM, VALPROIC ACID | DrugsGivenReaction | CC BY-NC-SA | 33944850 | 19,387,105 | 2021-04-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Underdose'. | Efficacy and safety of lacosamide in the treatment of status epilepticus in a patient with comorbidities.
Efficacy, safety and tolerability of lacosamide in the treatment of status epilepticus are well described. However, other evidence of its pharmacologic profile in elderly patients with other comorbidities seems war... | DIAZEPAM, LACOSAMIDE, LEVETIRACETAM, VALPROIC ACID | DrugsGivenReaction | CC BY-NC-SA | 33944850 | 19,685,604 | 2021-04-30 |
What was the administration route of drug 'DIAZEPAM'? | Efficacy and safety of lacosamide in the treatment of status epilepticus in a patient with comorbidities.
Efficacy, safety and tolerability of lacosamide in the treatment of status epilepticus are well described. However, other evidence of its pharmacologic profile in elderly patients with other comorbidities seems war... | Intravenous bolus | DrugAdministrationRoute | CC BY-NC-SA | 33944850 | 19,685,604 | 2021-04-30 |
What was the administration route of drug 'LACOSAMIDE'? | Efficacy and safety of lacosamide in the treatment of status epilepticus in a patient with comorbidities.
Efficacy, safety and tolerability of lacosamide in the treatment of status epilepticus are well described. However, other evidence of its pharmacologic profile in elderly patients with other comorbidities seems war... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-SA | 33944850 | 19,685,604 | 2021-04-30 |
What was the outcome of reaction 'Aphasia'? | Efficacy and safety of lacosamide in the treatment of status epilepticus in a patient with comorbidities.
Efficacy, safety and tolerability of lacosamide in the treatment of status epilepticus are well described. However, other evidence of its pharmacologic profile in elderly patients with other comorbidities seems war... | Recovered | ReactionOutcome | CC BY-NC-SA | 33944850 | 19,275,909 | 2021-04-30 |
What was the outcome of reaction 'Chronic kidney disease'? | Efficacy and safety of lacosamide in the treatment of status epilepticus in a patient with comorbidities.
Efficacy, safety and tolerability of lacosamide in the treatment of status epilepticus are well described. However, other evidence of its pharmacologic profile in elderly patients with other comorbidities seems war... | Recovered | ReactionOutcome | CC BY-NC-SA | 33944850 | 19,275,909 | 2021-04-30 |
What was the outcome of reaction 'Dysphagia'? | Efficacy and safety of lacosamide in the treatment of status epilepticus in a patient with comorbidities.
Efficacy, safety and tolerability of lacosamide in the treatment of status epilepticus are well described. However, other evidence of its pharmacologic profile in elderly patients with other comorbidities seems war... | Recovered | ReactionOutcome | CC BY-NC-SA | 33944850 | 19,275,909 | 2021-04-30 |
What was the outcome of reaction 'Hemiparesis'? | Efficacy and safety of lacosamide in the treatment of status epilepticus in a patient with comorbidities.
Efficacy, safety and tolerability of lacosamide in the treatment of status epilepticus are well described. However, other evidence of its pharmacologic profile in elderly patients with other comorbidities seems war... | Recovered | ReactionOutcome | CC BY-NC-SA | 33944850 | 19,275,909 | 2021-04-30 |
What was the outcome of reaction 'Pneumonia aspiration'? | Efficacy and safety of lacosamide in the treatment of status epilepticus in a patient with comorbidities.
Efficacy, safety and tolerability of lacosamide in the treatment of status epilepticus are well described. However, other evidence of its pharmacologic profile in elderly patients with other comorbidities seems war... | Recovered | ReactionOutcome | CC BY-NC-SA | 33944850 | 19,275,909 | 2021-04-30 |
What was the outcome of reaction 'Status epilepticus'? | Efficacy and safety of lacosamide in the treatment of status epilepticus in a patient with comorbidities.
Efficacy, safety and tolerability of lacosamide in the treatment of status epilepticus are well described. However, other evidence of its pharmacologic profile in elderly patients with other comorbidities seems war... | Recovered | ReactionOutcome | CC BY-NC-SA | 33944850 | 19,284,174 | 2021-04-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug abuse'. | Severe rhabdomyolysis induced by co-administration of cocaine and heroin in a 45 years old man treated with rosuvastatin: a case report.
The term rhabdomyolysis describes a damage involving striated muscle cells or fibers, often complicated by acute kidney injury. This syndrome can have different causes, but it is gene... | COCAINE, DIAMORPHINE, ROSUVASTATIN | DrugsGivenReaction | CC BY-NC-SA | 33944852 | 19,389,546 | 2021-04-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal failure'. | Severe rhabdomyolysis induced by co-administration of cocaine and heroin in a 45 years old man treated with rosuvastatin: a case report.
The term rhabdomyolysis describes a damage involving striated muscle cells or fibers, often complicated by acute kidney injury. This syndrome can have different causes, but it is gene... | COCAINE, DIAMORPHINE, ROSUVASTATIN | DrugsGivenReaction | CC BY-NC-SA | 33944852 | 19,471,568 | 2021-04-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Substance abuse'. | Severe rhabdomyolysis induced by co-administration of cocaine and heroin in a 45 years old man treated with rosuvastatin: a case report.
The term rhabdomyolysis describes a damage involving striated muscle cells or fibers, often complicated by acute kidney injury. This syndrome can have different causes, but it is gene... | COCAINE, DIAMORPHINE, ROSUVASTATIN CALCIUM | DrugsGivenReaction | CC BY-NC-SA | 33944852 | 19,373,087 | 2021-04-30 |
What was the dosage of drug 'COCAINE'? | Severe rhabdomyolysis induced by co-administration of cocaine and heroin in a 45 years old man treated with rosuvastatin: a case report.
The term rhabdomyolysis describes a damage involving striated muscle cells or fibers, often complicated by acute kidney injury. This syndrome can have different causes, but it is gene... | UNKNOWN | DrugDosageText | CC BY-NC-SA | 33944852 | 19,471,568 | 2021-04-30 |
What was the dosage of drug 'DIAMORPHINE'? | Severe rhabdomyolysis induced by co-administration of cocaine and heroin in a 45 years old man treated with rosuvastatin: a case report.
The term rhabdomyolysis describes a damage involving striated muscle cells or fibers, often complicated by acute kidney injury. This syndrome can have different causes, but it is gene... | UNKNOWN | DrugDosageText | CC BY-NC-SA | 33944852 | 19,471,568 | 2021-04-30 |
What was the dosage of drug 'ROSUVASTATIN CALCIUM'? | Severe rhabdomyolysis induced by co-administration of cocaine and heroin in a 45 years old man treated with rosuvastatin: a case report.
The term rhabdomyolysis describes a damage involving striated muscle cells or fibers, often complicated by acute kidney injury. This syndrome can have different causes, but it is gene... | 10 mg (milligrams). | DrugDosage | CC BY-NC-SA | 33944852 | 19,373,087 | 2021-04-30 |
What was the outcome of reaction 'Acute kidney injury'? | Severe rhabdomyolysis induced by co-administration of cocaine and heroin in a 45 years old man treated with rosuvastatin: a case report.
The term rhabdomyolysis describes a damage involving striated muscle cells or fibers, often complicated by acute kidney injury. This syndrome can have different causes, but it is gene... | Recovering | ReactionOutcome | CC BY-NC-SA | 33944852 | 19,373,087 | 2021-04-30 |
What was the outcome of reaction 'Renal failure'? | Severe rhabdomyolysis induced by co-administration of cocaine and heroin in a 45 years old man treated with rosuvastatin: a case report.
The term rhabdomyolysis describes a damage involving striated muscle cells or fibers, often complicated by acute kidney injury. This syndrome can have different causes, but it is gene... | Recovering | ReactionOutcome | CC BY-NC-SA | 33944852 | 19,471,568 | 2021-04-30 |
What was the administration route of drug 'HUMAN IMMUNOGLOBULIN G'? | Association of Immune Thrombocytopenia and Inflammatory Bowel Disease in Children.
BACKGROUND
The association between inflammatory bowel disease (IBD) and immune thrombocytopenia (ITP) is still uncertain. In this multicenter retrospective study, the coexistence of both diseases was investigated in children diagnosed fr... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33946596 | 19,862,589 | 2021-04-30 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Overdose'. | Peritoneal Tuberculosis during Infliximab Treatment in a Patient with Ulcerative Colitis Despite a Negative Quantiferon Test.
Infliximab is an IgG1 antitumor necrosis factor monoclonal antibody that is commonly used to treat inflammatory bowel disease (IBD) and other autoimmune disorders. However, it is known to increa... | INFLIXIMAB | DrugsGivenReaction | CC BY | 33946817 | 19,665,144 | 2021-04-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Peritoneal tuberculosis'. | Peritoneal Tuberculosis during Infliximab Treatment in a Patient with Ulcerative Colitis Despite a Negative Quantiferon Test.
Infliximab is an IgG1 antitumor necrosis factor monoclonal antibody that is commonly used to treat inflammatory bowel disease (IBD) and other autoimmune disorders. However, it is known to increa... | INFLIXIMAB | DrugsGivenReaction | CC BY | 33946817 | 19,665,144 | 2021-04-29 |
What was the administration route of drug 'INFLIXIMAB'? | Peritoneal Tuberculosis during Infliximab Treatment in a Patient with Ulcerative Colitis Despite a Negative Quantiferon Test.
Infliximab is an IgG1 antitumor necrosis factor monoclonal antibody that is commonly used to treat inflammatory bowel disease (IBD) and other autoimmune disorders. However, it is known to increa... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33946817 | 19,420,856 | 2021-04-29 |
What was the dosage of drug 'INFLIXIMAB'? | Peritoneal Tuberculosis during Infliximab Treatment in a Patient with Ulcerative Colitis Despite a Negative Quantiferon Test.
Infliximab is an IgG1 antitumor necrosis factor monoclonal antibody that is commonly used to treat inflammatory bowel disease (IBD) and other autoimmune disorders. However, it is known to increa... | 10 MG/KG | DrugDosageText | CC BY | 33946817 | 19,665,144 | 2021-04-29 |
What was the outcome of reaction 'Peritoneal tuberculosis'? | Peritoneal Tuberculosis during Infliximab Treatment in a Patient with Ulcerative Colitis Despite a Negative Quantiferon Test.
Infliximab is an IgG1 antitumor necrosis factor monoclonal antibody that is commonly used to treat inflammatory bowel disease (IBD) and other autoimmune disorders. However, it is known to increa... | Recovered | ReactionOutcome | CC BY | 33946817 | 19,665,144 | 2021-04-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Aggression'. | Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients.
OBJECTIVE
An effective treatment option is not yet available for SARS-CoV2, which causes the COVID-19 pandemic and whose effects are felt more and more every day. Ivermectin is among the drugs whose effectiveness i... | AZITHROMYCIN ANHYDROUS, FAVIPIRAVIR, HYDROXYCHLOROQUINE, IVERMECTIN | DrugsGivenReaction | CC BY | 33947344 | 19,300,666 | 2021-05-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Agitation'. | Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients.
OBJECTIVE
An effective treatment option is not yet available for SARS-CoV2, which causes the COVID-19 pandemic and whose effects are felt more and more every day. Ivermectin is among the drugs whose effectiveness i... | AZITHROMYCIN ANHYDROUS, FAVIPIRAVIR, HYDROXYCHLOROQUINE, IVERMECTIN | DrugsGivenReaction | CC BY | 33947344 | 19,300,666 | 2021-05-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Altered state of consciousness'. | Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients.
OBJECTIVE
An effective treatment option is not yet available for SARS-CoV2, which causes the COVID-19 pandemic and whose effects are felt more and more every day. Ivermectin is among the drugs whose effectiveness i... | AZITHROMYCIN ANHYDROUS, FAVIPIRAVIR, HYDROXYCHLOROQUINE, IVERMECTIN | DrugsGivenReaction | CC BY | 33947344 | 19,300,666 | 2021-05-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Delirium'. | Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients.
OBJECTIVE
An effective treatment option is not yet available for SARS-CoV2, which causes the COVID-19 pandemic and whose effects are felt more and more every day. Ivermectin is among the drugs whose effectiveness i... | AZITHROMYCIN ANHYDROUS, FAVIPIRAVIR, HYDROXYCHLOROQUINE, IVERMECTIN | DrugsGivenReaction | CC BY | 33947344 | 19,300,666 | 2021-05-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients.
OBJECTIVE
An effective treatment option is not yet available for SARS-CoV2, which causes the COVID-19 pandemic and whose effects are felt more and more every day. Ivermectin is among the drugs whose effectiveness i... | AZITHROMYCIN ANHYDROUS, FAVIPIRAVIR, HYDROXYCHLOROQUINE, IVERMECTIN | DrugsGivenReaction | CC BY | 33947344 | 19,300,666 | 2021-05-04 |
What was the administration route of drug 'AZITHROMYCIN ANHYDROUS'? | Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients.
OBJECTIVE
An effective treatment option is not yet available for SARS-CoV2, which causes the COVID-19 pandemic and whose effects are felt more and more every day. Ivermectin is among the drugs whose effectiveness i... | Oral | DrugAdministrationRoute | CC BY | 33947344 | 19,300,666 | 2021-05-04 |
What was the administration route of drug 'FAVIPIRAVIR'? | Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients.
OBJECTIVE
An effective treatment option is not yet available for SARS-CoV2, which causes the COVID-19 pandemic and whose effects are felt more and more every day. Ivermectin is among the drugs whose effectiveness i... | Oral | DrugAdministrationRoute | CC BY | 33947344 | 19,300,666 | 2021-05-04 |
What was the administration route of drug 'HYDROXYCHLOROQUINE'? | Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients.
OBJECTIVE
An effective treatment option is not yet available for SARS-CoV2, which causes the COVID-19 pandemic and whose effects are felt more and more every day. Ivermectin is among the drugs whose effectiveness i... | Oral | DrugAdministrationRoute | CC BY | 33947344 | 19,300,666 | 2021-05-04 |
What was the administration route of drug 'IVERMECTIN'? | Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients.
OBJECTIVE
An effective treatment option is not yet available for SARS-CoV2, which causes the COVID-19 pandemic and whose effects are felt more and more every day. Ivermectin is among the drugs whose effectiveness i... | Oral | DrugAdministrationRoute | CC BY | 33947344 | 19,300,666 | 2021-05-04 |
What was the dosage of drug 'IVERMECTIN'? | Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients.
OBJECTIVE
An effective treatment option is not yet available for SARS-CoV2, which causes the COVID-19 pandemic and whose effects are felt more and more every day. Ivermectin is among the drugs whose effectiveness i... | 200 ?G/KG, QD (FIRST DOSE) | DrugDosageText | CC BY | 33947344 | 19,300,666 | 2021-05-04 |
What was the outcome of reaction 'Aggression'? | Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients.
OBJECTIVE
An effective treatment option is not yet available for SARS-CoV2, which causes the COVID-19 pandemic and whose effects are felt more and more every day. Ivermectin is among the drugs whose effectiveness i... | Recovered | ReactionOutcome | CC BY | 33947344 | 19,300,666 | 2021-05-04 |
What was the outcome of reaction 'Agitation'? | Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients.
OBJECTIVE
An effective treatment option is not yet available for SARS-CoV2, which causes the COVID-19 pandemic and whose effects are felt more and more every day. Ivermectin is among the drugs whose effectiveness i... | Recovered | ReactionOutcome | CC BY | 33947344 | 19,300,666 | 2021-05-04 |
What was the outcome of reaction 'Altered state of consciousness'? | Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients.
OBJECTIVE
An effective treatment option is not yet available for SARS-CoV2, which causes the COVID-19 pandemic and whose effects are felt more and more every day. Ivermectin is among the drugs whose effectiveness i... | Recovered | ReactionOutcome | CC BY | 33947344 | 19,300,666 | 2021-05-04 |
What was the outcome of reaction 'Delirium'? | Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients.
OBJECTIVE
An effective treatment option is not yet available for SARS-CoV2, which causes the COVID-19 pandemic and whose effects are felt more and more every day. Ivermectin is among the drugs whose effectiveness i... | Recovered | ReactionOutcome | CC BY | 33947344 | 19,300,666 | 2021-05-04 |
What was the outcome of reaction 'Product use in unapproved indication'? | Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients.
OBJECTIVE
An effective treatment option is not yet available for SARS-CoV2, which causes the COVID-19 pandemic and whose effects are felt more and more every day. Ivermectin is among the drugs whose effectiveness i... | Recovered | ReactionOutcome | CC BY | 33947344 | 19,300,666 | 2021-05-04 |
What was the dosage of drug 'DEXAMETHASONE'? | Multidisciplinary corroboration in differentiation syndrome: a case report.
BACKGROUND
Differentiation syndrome (DS) is a life-threatening complication that may be seen in patients with acute promyelocytic leukaemia undergoing induction therapy with all-trans retinoic acid or arsenic trioxide. It can lead to severe inf... | 10 MILLIGRAM/SQ. METER | DrugDosageText | CC BY | 33947461 | 19,385,974 | 2021-05-05 |
What was the outcome of reaction 'Differentiation syndrome'? | Multidisciplinary corroboration in differentiation syndrome: a case report.
BACKGROUND
Differentiation syndrome (DS) is a life-threatening complication that may be seen in patients with acute promyelocytic leukaemia undergoing induction therapy with all-trans retinoic acid or arsenic trioxide. It can lead to severe inf... | Recovering | ReactionOutcome | CC BY | 33947461 | 19,275,343 | 2021-05-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Tolvaptan treatment in an adult Fontan patient with protein-losing enteropathy: a serial 23Na-MRI investigation.
Protein-losing enteropathy (PLE) is a severe complication of the univentricular Fontan circulation and associated with disturbances in salt and water homeostasis. Fontan patients with PLE have a poor prognos... | BUDESONIDE, EPLERENONE, FUROSEMIDE, HEPARIN SODIUM, HYDROCHLOROTHIAZIDE, IODINE, LEVOTHYROXINE, LOSARTAN, METILDIGOXIN, PANTOPRAZOLE, SILDENAFIL, VITAMIN D NOS | DrugsGivenReaction | CC BY | 33948157 | 19,963,275 | 2021 |
What was the administration route of drug 'BUDESONIDE'? | Tolvaptan treatment in an adult Fontan patient with protein-losing enteropathy: a serial 23Na-MRI investigation.
Protein-losing enteropathy (PLE) is a severe complication of the univentricular Fontan circulation and associated with disturbances in salt and water homeostasis. Fontan patients with PLE have a poor prognos... | Oral | DrugAdministrationRoute | CC BY | 33948157 | 19,941,818 | 2021 |
What was the administration route of drug 'FUROSEMIDE'? | Tolvaptan treatment in an adult Fontan patient with protein-losing enteropathy: a serial 23Na-MRI investigation.
Protein-losing enteropathy (PLE) is a severe complication of the univentricular Fontan circulation and associated with disturbances in salt and water homeostasis. Fontan patients with PLE have a poor prognos... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33948157 | 19,963,275 | 2021 |
What was the dosage of drug 'ALLOPURINOL'? | Tolvaptan treatment in an adult Fontan patient with protein-losing enteropathy: a serial 23Na-MRI investigation.
Protein-losing enteropathy (PLE) is a severe complication of the univentricular Fontan circulation and associated with disturbances in salt and water homeostasis. Fontan patients with PLE have a poor prognos... | 2 MILLIGRAM/KILOGRAM, QD | DrugDosageText | CC BY | 33948157 | 19,944,971 | 2021 |
What was the dosage of drug 'EPLERENONE'? | Tolvaptan treatment in an adult Fontan patient with protein-losing enteropathy: a serial 23Na-MRI investigation.
Protein-losing enteropathy (PLE) is a severe complication of the univentricular Fontan circulation and associated with disturbances in salt and water homeostasis. Fontan patients with PLE have a poor prognos... | 1 MILLIGRAM/KILOGRAM, QD | DrugDosageText | CC BY | 33948157 | 19,963,275 | 2021 |
What was the dosage of drug 'ERGOCALCIFEROL'? | Tolvaptan treatment in an adult Fontan patient with protein-losing enteropathy: a serial 23Na-MRI investigation.
Protein-losing enteropathy (PLE) is a severe complication of the univentricular Fontan circulation and associated with disturbances in salt and water homeostasis. Fontan patients with PLE have a poor prognos... | 1000 INTERNATIONAL UNIT, QD | DrugDosageText | CC BY | 33948157 | 19,944,971 | 2021 |
What was the dosage of drug 'IODINE'? | Tolvaptan treatment in an adult Fontan patient with protein-losing enteropathy: a serial 23Na-MRI investigation.
Protein-losing enteropathy (PLE) is a severe complication of the univentricular Fontan circulation and associated with disturbances in salt and water homeostasis. Fontan patients with PLE have a poor prognos... | 6 MILLIGRAM/KILOGRAM, QD | DrugDosageText | CC BY | 33948157 | 19,963,275 | 2021 |
What was the dosage of drug 'LEVOTHYROXINE'? | Tolvaptan treatment in an adult Fontan patient with protein-losing enteropathy: a serial 23Na-MRI investigation.
Protein-losing enteropathy (PLE) is a severe complication of the univentricular Fontan circulation and associated with disturbances in salt and water homeostasis. Fontan patients with PLE have a poor prognos... | 2 MICROGRAM/KILOGRAM, QD | DrugDosageText | CC BY | 33948157 | 19,963,275 | 2021 |
What was the dosage of drug 'LOSARTAN'? | Tolvaptan treatment in an adult Fontan patient with protein-losing enteropathy: a serial 23Na-MRI investigation.
Protein-losing enteropathy (PLE) is a severe complication of the univentricular Fontan circulation and associated with disturbances in salt and water homeostasis. Fontan patients with PLE have a poor prognos... | 0.188 MILLIGRAM/KILOGRAM, QD | DrugDosageText | CC BY | 33948157 | 19,963,275 | 2021 |
What was the dosage of drug 'METILDIGOXIN'? | Tolvaptan treatment in an adult Fontan patient with protein-losing enteropathy: a serial 23Na-MRI investigation.
Protein-losing enteropathy (PLE) is a severe complication of the univentricular Fontan circulation and associated with disturbances in salt and water homeostasis. Fontan patients with PLE have a poor prognos... | 0.002 MILLIGRAM/KILOGRAM, QD | DrugDosageText | CC BY | 33948157 | 19,963,275 | 2021 |
What was the dosage of drug 'PANTOPRAZOLE'? | Tolvaptan treatment in an adult Fontan patient with protein-losing enteropathy: a serial 23Na-MRI investigation.
Protein-losing enteropathy (PLE) is a severe complication of the univentricular Fontan circulation and associated with disturbances in salt and water homeostasis. Fontan patients with PLE have a poor prognos... | 1.2 MILLIGRAM/KILOGRAM, QD | DrugDosageText | CC BY | 33948157 | 19,963,275 | 2021 |
What was the dosage of drug 'SILDENAFIL'? | Tolvaptan treatment in an adult Fontan patient with protein-losing enteropathy: a serial 23Na-MRI investigation.
Protein-losing enteropathy (PLE) is a severe complication of the univentricular Fontan circulation and associated with disturbances in salt and water homeostasis. Fontan patients with PLE have a poor prognos... | 0.6 MILLIGRAM/KILOGRAM, QD | DrugDosageText | CC BY | 33948157 | 19,963,275 | 2021 |
What was the dosage of drug 'VITAMIN D NOS'? | Tolvaptan treatment in an adult Fontan patient with protein-losing enteropathy: a serial 23Na-MRI investigation.
Protein-losing enteropathy (PLE) is a severe complication of the univentricular Fontan circulation and associated with disturbances in salt and water homeostasis. Fontan patients with PLE have a poor prognos... | 1000 INTERNATIONAL UNIT, QD | DrugDosageText | CC BY | 33948157 | 19,963,275 | 2021 |
What was the administration route of drug 'PREDNISOLONE'? | Dupilumab: a new contestant to corticosteroid in allergic bronchopulmonary aspergillosis.
Allergic bronchopulmonary aspergillosis (ABPA) is a disease characterized by severe disability with recurrent wheezing and shortness of breath. The current recommended therapy is daily oral corticosteroids +/- oral antifungal ther... | Oral | DrugAdministrationRoute | CC BY-NC | 33948179 | 20,941,490 | 2021-04 |
What was the administration route of drug 'PREDNISONE'? | Dupilumab: a new contestant to corticosteroid in allergic bronchopulmonary aspergillosis.
Allergic bronchopulmonary aspergillosis (ABPA) is a disease characterized by severe disability with recurrent wheezing and shortness of breath. The current recommended therapy is daily oral corticosteroids +/- oral antifungal ther... | Oral | DrugAdministrationRoute | CC BY-NC | 33948179 | 20,794,399 | 2021-04 |
What was the administration route of drug 'THEOPHYLLINE'? | Dupilumab: a new contestant to corticosteroid in allergic bronchopulmonary aspergillosis.
Allergic bronchopulmonary aspergillosis (ABPA) is a disease characterized by severe disability with recurrent wheezing and shortness of breath. The current recommended therapy is daily oral corticosteroids +/- oral antifungal ther... | Respiratory (inhalation) | DrugAdministrationRoute | CC BY-NC | 33948179 | 20,941,490 | 2021-04 |
What was the administration route of drug 'ZAFIRLUKAST'? | Dupilumab: a new contestant to corticosteroid in allergic bronchopulmonary aspergillosis.
Allergic bronchopulmonary aspergillosis (ABPA) is a disease characterized by severe disability with recurrent wheezing and shortness of breath. The current recommended therapy is daily oral corticosteroids +/- oral antifungal ther... | Respiratory (inhalation) | DrugAdministrationRoute | CC BY-NC | 33948179 | 20,941,490 | 2021-04 |
What was the dosage of drug 'THEOPHYLLINE'? | Dupilumab: a new contestant to corticosteroid in allergic bronchopulmonary aspergillosis.
Allergic bronchopulmonary aspergillosis (ABPA) is a disease characterized by severe disability with recurrent wheezing and shortness of breath. The current recommended therapy is daily oral corticosteroids +/- oral antifungal ther... | UNK, RESPIRATORY (INHALATION) | DrugDosageText | CC BY-NC | 33948179 | 20,941,490 | 2021-04 |
What was the dosage of drug 'ZAFIRLUKAST'? | Dupilumab: a new contestant to corticosteroid in allergic bronchopulmonary aspergillosis.
Allergic bronchopulmonary aspergillosis (ABPA) is a disease characterized by severe disability with recurrent wheezing and shortness of breath. The current recommended therapy is daily oral corticosteroids +/- oral antifungal ther... | UNK, RESPIRATORY (INHALATION) | DrugDosageText | CC BY-NC | 33948179 | 20,941,490 | 2021-04 |
What was the administration route of drug 'DEXAMETHASONE'? | Sertraline as a rare cause of interstitial lung disease.
Sertraline, a selective serotonin reuptake inhibitor, is commonly prescribed for the treatment of moderate-to-severe depression. We report a case of a 36-year-old male taking sertraline for 7 weeks prior to developing a dry cough, pleuritic chest pain, hypoxia an... | Oral | DrugAdministrationRoute | CC BY-NC | 33948187 | 20,718,555 | 2021-04 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.